Aktis Oncology, Inc.
AKTS$19.87▲ 2.58% 24h
Aktis Oncology, Inc.AKTS$19.87
+$0.6595(+3.43%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.38
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$3.23M
Net income
$-18.32M
Net margin
-567.9%
Gross margin
—
Dividends & financials
Aktis Oncology, Inc. (AKTS) reported revenue of $3.23M and net income of $-18.32M, or $-0.38 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.